{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T10:01:27Z","timestamp":1709632887220},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,3,15]]},"DOI":"10.2169\/internalmedicine.5920-20","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:08:16Z","timestamp":1603231696000},"page":"859-866","source":"Crossref","is-referenced-by-count":2,"title":["IgG4-related Sclerosing Cholangitis Complicated with Cholangiocarcinoma and Detected by Forkhead Box P3 Immunohistochemical Staining"],"prefix":"10.2169","volume":"60","author":[{"given":"Tadashi","family":"Toyohara","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kais","family":"Zakharia","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Miyabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Kanazawa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Notohara","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Kurashiki Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Naitoh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and extra-intestinal manifestations of IgG4-related disease. Gastroenterology 155: 990-1003 e1001, 2018.","DOI":"10.1053\/j.gastro.2018.06.082"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19: 536-542, 2012.","DOI":"10.1007\/s00534-012-0521-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kamisawa T, Nakazawa T, Tazuma S, et al. Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 26: 9-42, 2019.","DOI":"10.1002\/jhbp.596"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakazawa T, Shimizu S, Naitoh I. IgG4-related sclerosing cholangitis. Semin Liver Dis 36: 216-228, 2016.","DOI":"10.1055\/s-0036-1584321"},{"key":"5","unstructured":"5. Ohara H, Nakazawa T, Kawa S, et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28: 1247-1251, 2013."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. von Hahn T, Ciesek S, Wegener G, et al. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scand J Gastroenterol 46: 1092-1098, 2011.","DOI":"10.3109\/00365521.2011.589472"},{"key":"7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2012.173","volume":"107","author":"JD Yang","year":"2012","unstructured":"7. Yang JD, Kim B, Sanderson SO, et al. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. The American journal of gastroenterology 107: 1256-1262, 2012.","journal-title":"The American Journal of Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145: 1215-1229, 2013.","DOI":"10.1053\/j.gastro.2013.10.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362: 1273-1281, 2010.","DOI":"10.1056\/NEJMoa0908721"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Harada K, Nakanuma Y. Cholangiocarcinoma with respect to IgG4 reaction. Int J Hepatol 2014: 803876, 2014.","DOI":"10.1155\/2014\/803876"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Harada K, Shimoda S, Kimura Y, et al. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 56: 157-164, 2012.","DOI":"10.1002\/hep.25627"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40: 352-358, 2011.","DOI":"10.1097\/MPA.0b013e3182142fd2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol 44: 1147-1155, 2009.","DOI":"10.1007\/s00535-009-0108-9"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Inoue H, Miyatani H, Sawada Y, et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 33: 208-209, 2006.","DOI":"10.1097\/01.mpa.0000232329.35822.3a"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25: 1181-1192, 2012.","DOI":"10.1038\/modpathol.2012.72"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zen Y, Liberal R, Nakanuma Y, et al. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis. J Hepatol 59: 1059-1064, 2013.","DOI":"10.1016\/j.jhep.2013.06.016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68-73, 2001.","DOI":"10.1038\/83784"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003.","DOI":"10.1126\/science.1079490"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ebert LM, Tan BS, Browning J, et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 68: 3001-3009, 2008.","DOI":"10.1158\/0008-5472.CAN-07-5664"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Karanikas V, Speletas M, Zamanakou M, et al. Foxp3 expression in human cancer cells. J Transl Med 6: 19, 2008.","DOI":"10.1186\/1479-5876-6-19"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ito F, Kamekura R, Yamamoto M, et al. IL-10 (+) T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease. Immunol Lett 207: 56-63, 2019.","DOI":"10.1016\/j.imlet.2019.01.008"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Kusuda T, Uchida K, Miyoshi H, et al. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis. Pancreas 40: 1120-1130, 2011.","DOI":"10.1097\/MPA.0b013e31821fc796"},{"key":"23","unstructured":"23. Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13: 759-771, 2013."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kitano Y, Okabe H, Yamashita YI, et al. Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma. Br J Cancer 118: 171-180, 2018.","DOI":"10.1038\/bjc.2017.401"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kimura Y, Harada K, Nakanuma Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma. Hum Pathol 43: 2149-2156, 2012.","DOI":"10.1016\/j.humpath.2012.03.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Douhara A, Mitoro A, Otani E, et al. Cholangiocarcinoma developed in a patient with IgG4-related disease. World J Gastrointest Oncol 5: 181-185, 2013.","DOI":"10.4251\/wjgo.v5.i8.181"},{"key":"27","unstructured":"27. Zhang YA, Shen XZ, Zhu JM, et al. Extensive metastatic cholangiocarcinoma associated with IgG4-related sclerosing cholangitis misdiagnosed as isolated IgG4-related sclerosing cholangitis: a case report and literature review. Medicine (Baltimore) 94: e2052, 2015."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Straub BK, Esposito I, Gotthardt D, et al. IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch 458: 761-765, 2011.","DOI":"10.1007\/s00428-011-1073-2"},{"key":"29","unstructured":"29. Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 21: 671-684, 2020."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/6\/60_5920-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:38:22Z","timestamp":1696919902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/6\/60_5920-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5920-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]}}}